Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

by Heilbron, Eric , Kawazoe, Akihito , Stein, Alexander , Wyrwicz, Lucjan , Kurland, John F. , Tabernero, Josep , Alvarenga, Maria Lorena , Oliden, Victor Castro , Molena, Daniela , Omori, Takeshi , Garrido, Marcelo , Hyung, Woo Jin , Janjigian, Yelena Y. , Kozlov, Vadim , Van Cutsem, Eric , Oh, Do-Youn , Oliveira, Sulene C.S. , Bilici, Mehmet , Smyth, Elizabeth C. , Serrano, Olivier , Negro, Alejandra , Liberman, Moishe , Moehler, Markus , Al-Batran, Salah-Eddin , Wainberg, Zev A. , Muro, Kei , Rivera, Fernando

in 5-Fluorouracil / Adenocarcinoma / Adenocarcinoma - drug therapy / Adenocarcinoma - mortality / Adenocarcinoma - pathology / Adenocarcinoma - surgery / Adjuvant therapy / Adjuvants / Adult / Aged / Aged, 80 and over / Antibodies, Monoclonal - administration & dosage / Antibodies, Monoclonal - adverse effects / Antineoplastic Agents, Immunological - administration & dosage / Antineoplastic Agents, Immunological - adverse effects / Antineoplastic Combined Chemotherapy Protocols - administration & dosage / Antineoplastic Combined Chemotherapy Protocols - adverse effects / Biopsy / Cancer therapies / Chemotherapy / Chemotherapy, Adjuvant - adverse effects / Chemotherapy, Adjuvant - methods / Clinical medicine / Consent / Docetaxel - administration & dosage / Docetaxel - adverse effects / Double-Blind Method / Esophageal Neoplasms - drug therapy / Esophageal Neoplasms - mortality / Esophageal Neoplasms - pathology / Esophageal Neoplasms - surgery / Esophagogastric Junction - pathology / Esophagogastric Junction - surgery / Female / Fluorouracil - administration & dosage / Fluorouracil - adverse effects / Gastroenterology / Gastrointestinal Tract Cancer / Hematology / Humans / Immunotherapy / Kaplan-Meier Estimate / Leucovorin - administration & dosage / Leucovorin - adverse effects / Male / Metastasis / Middle Aged / Neoadjuvant Therapy - adverse effects / Neoadjuvant Therapy - methods / Oncology / Oxaliplatin / Oxaliplatin - administration & dosage / Oxaliplatin - adverse effects / Perioperative Care - adverse effects / Perioperative Care - methods / Placebos / Statistical analysis / Stomach Neoplasms - drug therapy / Stomach Neoplasms - mortality / Stomach Neoplasms - pathology / Stomach Neoplasms - surgery / Surgery / Survival / Survival analysis / Treatment Outcome / Treatments in Oncology / Tumors

2025

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

2025

Confirm

Do you wish to request the book?

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

2025

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Heilbron, Eric,

Kawazoe, Akihito,

Stein, Alexander,

Wyrwicz, Lucjan,

Kurland, John F.,

Tabernero, Josep,

Alvarenga, Maria Lorena,

Oliden, Victor Castro,

Molena, Daniela,

Omori, Takeshi,

Garrido, Marcelo,

Hyung, Woo Jin,

Janjigian, Yelena Y.,

Kozlov, Vadim,

Van Cutsem, Eric,

Oh, Do-Youn,

Oliveira, Sulene C.S.,

Bilici, Mehmet,

Smyth, Elizabeth C.,

Serrano, Olivier,

Negro, Alejandra,

Liberman, Moishe,

Moehler, Markus,

Al-Batran, Salah-Eddin,

Wainberg, Zev A.,

Muro, Kei,

Rivera, Fernando

2025

Overview

In resectable gastric and gastroesophageal junction cancer, adding durvalumab to perioperative chemotherapy improved event-free survival and pathological complete response, with no major increase in high-grade adverse events.

Share this book

Add to My Shelf

Publisher

Massachusetts Medical Society

Subject

5-Fluorouracil

/ Adenocarcinoma

/ Adenocarcinoma - drug therapy

/ Adenocarcinoma - mortality

/ Adenocarcinoma - pathology

/ Adenocarcinoma - surgery

/ Adjuvant therapy